FDC has received approval for buyback of its own fully paid up equity shares of Re 1 each equity shares from the equity shareholders of the Company, not exceeding 34,30,000 fully paid up Equity Shares at a price of Rs 350 per equity share for an aggregate amount not exceeding Rs 120.05 crore being less than 10% of the Paid Up Capital and free reserves as on March 31, 2019 from the existing equity shareholders of the Company. The Board of Directors of the Company at its meeting held on May 24, 2019 has approved the same.
FDC is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: